Literature DB >> 15350900

The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis.

Robert E Barry1, Wilhelm Krek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15350900     DOI： 10.1016/j.molmed.2004.07.008

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN： 1471-4914            Impact factor:   11.951


× No keyword cloud information.
  20 in total

1.  Proteomic dissection of the von Hippel-Lindau (VHL) interactome.

Authors:  Yanlai Lai; Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  J Proteome Res       Date:  2011-10-11       Impact factor: 4.466

2.  Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.

Authors:  Brenda L Petrella; Jouko Lohi; Constance E Brinckerhoff
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

3.  The von Hippel-Lindau tumour-suppressor protein interaction with protein kinase Cdelta.

Authors:  Xavier Iturrioz; Joanne Durgan; Véronique Calleja; Banafshé Larijani; Heiwa Okuda; Richard Whelan; Peter J Parker
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

Review 4.  Von Hippel-Lindau syndrome: molecular mechanisms of the disease.

Authors:  María J Calzada
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

5.  Metastatic Renal Cell Cancer-Systemic Therapy.

Authors:  Amit Joshi; Arvind Sahu; Vanita Noronha; Vijay Patil; Kumar Prabhash
Journal:  Indian J Surg Oncol       Date:  2018-01-29

6.  The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1.

Authors:  Yanlai Lai; Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  Arch Biochem Biophys       Date:  2012-01-03       Impact factor: 4.013

7.  Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis.

Authors:  Wai T Wong; Elvira Agrón; Hanna R Coleman; George F Reed; Karl Csaky; James Peterson; Gladys Glenn; W Marston Linehan; Paul Albert; Emily Y Chew
Journal:  Arch Ophthalmol       Date:  2007-02

8.  Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3.

Authors:  Alexander Hergovich; Joanna Lisztwan; Claudio R Thoma; Christiane Wirbelauer; Robert E Barry; Wilhelm Krek
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

9.  [Von-Hippel-Lindau gene mutation types. Association of gene expression signatures in clear cell renal cell carcinoma].

Authors:  V D Luu; B Fischer; A von Teichman; G Boysen; K Mertz; P Zimmermann; H Moch; P Schraml
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

10.  Identification of 3 novel VHL germ-line mutations in Danish VHL patients.

Authors:  Mette Dandanell; Lennart Friis-Hansen; Lone Sunde; Finn C Nielsen; Thomas V O Hansen
Journal:  BMC Med Genet       Date:  2012-07-16       Impact factor: 2.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.